These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22484151)

  • 1. Docetaxel vs. vinorelbine in elderly patients with advanced non-small-cell lung cancer.
    Kurishima K; Kagohashi K; Ishikawa H; Satoh H
    Clin Lung Cancer; 2012 Sep; 13(5):396; author reply 397. PubMed ID: 22484151
    [No Abstract]   [Full Text] [Related]  

  • 2. Docetaxel vs. vinorelbine in elderly patients with advanced non--small-cell lung cancer: a hellenic oncology research group randomized phase III study.
    Karampeazis A; Vamvakas L; Agelidou A; Kentepozidis N; Chainis K; Chandrinos V; Vardakis N; Pallis AG; Christophyllakis C; Georgoulias V
    Clin Lung Cancer; 2011 May; 12(3):155-60. PubMed ID: 21663857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New drugs in non-small cell lung cancer. An overview.
    Giaccone G
    Lung Cancer; 1995 Apr; 12 Suppl 1():S155-62. PubMed ID: 7551924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I trial of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer.
    Govindan R; Lim WT; Arquette MA; Goodner SA; Fears CL; Mortimer JE; Fracasso PM
    Oncol Rep; 2006 Jan; 15(1):123-7. PubMed ID: 16328044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docetaxel as monotherapy in the treatment of advanced non-small-cell lung cancer in elderly patients.
    Malani AK; Abou-Jawde RM; Singh J; Taylor SA
    J Clin Oncol; 2007 Mar; 25(9):1143-4; author reply 1144. PubMed ID: 17369581
    [No Abstract]   [Full Text] [Related]  

  • 6. Vinorelbine approved for advanced non-small-cell lung cancer.
    Am J Health Syst Pharm; 1995 Apr; 52(7):678. PubMed ID: 7627734
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemo-naïve non-small-cell lung cancer in Taiwan.
    Chen YM; Perng RP; Shih JF; Tsai CM; Whang-Peng J
    Lung Cancer; 2007 Jun; 56(3):363-9. PubMed ID: 17306906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904).
    Kudoh S; Takeda K; Nakagawa K; Takada M; Katakami N; Matsui K; Shinkai T; Sawa T; Goto I; Semba H; Seto T; Ando M; Satoh T; Yoshimura N; Negoro S; Fukuoka M
    J Clin Oncol; 2006 Aug; 24(22):3657-63. PubMed ID: 16877734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination docetaxel/vinorelbine for metastatic breast cancer and non-small-cell lung cancer.
    Aapro MS
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):46-9. PubMed ID: 9364543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vinorelbine for treatment of advanced non-small-cell lung cancer.
    Med Lett Drugs Ther; 1995 Aug; 37(955):72-3. PubMed ID: 7630328
    [No Abstract]   [Full Text] [Related]  

  • 11. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
    Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trials of vinorelbine and docetaxel in the treatment of advanced non-small cell lung cancer.
    Krug LM; Miller VA
    Semin Oncol; 1999 Oct; 26(5 Suppl 16):24-6; discussion 41-2. PubMed ID: 10585005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancer.
    Georgoulias V; Kourousis C; Androulakis N; Kakolyris S; Papadakis E; Bouros D; Apostolopoulou F; Georgopoulou T; Agelidou M; Souglakos J; Halkiadakis G; Hatzidaki D
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-9-S14-14. PubMed ID: 9335517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of docetaxel and vinorelbine in patients with advanced non-small-cell lung cancer.
    Miller VA; Krug LM; Ng KK; Pizzo B; Perez W; Heelan RT; Kris MG
    J Clin Oncol; 2000 Mar; 18(6):1346-50. PubMed ID: 10715307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docetaxel (Taxotere) in combination with vinorelbine in non-small cell lung cancer.
    Miller V
    Semin Oncol; 1999 Jun; 26(3 Suppl 10):12-4. PubMed ID: 10437745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do elderly patients with non-small cell lung cancer get the best out of recent advances in first-line treatment? A comparative study in two tertiary cancer centers in Greece.
    Bakogeorgos M; Mountzios G; Bournakis E; Economopoulou P; Kotsantis G; Fytrakis N; Kouvatseas G; Dimopoulos MA; Kentepozidis N
    J Geriatr Oncol; 2015 Mar; 6(2):111-8. PubMed ID: 25482021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erlotinib versus docetaxel as second- or third-line therapy in patients with advanced non-small-cell lung cancer in the era of personalized medicine.
    Biswas B
    J Clin Oncol; 2015 Feb; 33(5):524. PubMed ID: 25584001
    [No Abstract]   [Full Text] [Related]  

  • 18. Gefitinib or docetaxel in advanced non-small-cell lung cancer.
    Cullen M; Thatcher N
    Lancet; 2008 Nov; 372(9652):1785-6. PubMed ID: 19027472
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of vinorelbine monotherapy in taxane-treated patients with advanced non-small-cell lung cancer.
    Miyata J; Sano T; Bando H
    Med Oncol; 2002; 19(1):11-4. PubMed ID: 12025886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vinorelbine in the treatment of non-small-cell lung cancer and breast cancer].
    Kubota K
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1301-6. PubMed ID: 10945030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.